Genworth Financial (GNW) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Net income for Q3 2024 was $85 million ($0.19 per share), up from $29 million in Q3 2023; adjusted operating income was $48 million ($0.11 per share), with Enact contributing $148 million and $81 million in capital returns.
U.S. life insurance companies' RBC ratio was 317%, with holding company cash and liquid assets at $369 million at quarter-end.
Strategic priorities include maximizing Enact's value, stabilizing legacy LTC and annuity businesses, and scaling CareScout, which expanded to 49 states covering over 75% of the U.S. 65+ population.
Share repurchases totaled $36 million in Q3 and $144 million year-to-date; $17 million in holding company debt was repurchased at a discount.
For the nine months ended September 30, 2024, net income was $300 million and adjusted operating income was $258 million.
Financial highlights
Q3 2024 total revenues were $1.88 billion, up 3% year-over-year; net investment income was $777 million, down 3%.
Enact's adjusted operating income rose 10% year-over-year to $148 million, driven by reserve releases, higher investment income, and favorable cure performance.
Long-term care insurance segment posted a $46 million adjusted operating loss, mainly from liability remeasurement losses and higher claims.
Life and annuities segment had a $27 million adjusted operating loss, with life insurance specifically losing $40 million due to unfavorable mortality.
Corporate and Other segment reported a $27 million loss, reflecting interest expense, CareScout investments, and tax timing.
Outlook and guidance
Management expects Enact capital returns for 2024 at the upper end of $245 million–$285 million guidance, supporting share repurchases and strategic initiatives.
CareScout plans to expand its network to 80–85% of the U.S. 65+ population by year-end and launch an insurance product in 2025.
Ongoing focus on LTCI in-force rate actions, with $30 billion cumulative economic benefit since 2012; Q4 2024 assumption reviews may result in negative but small reserve impacts.
Share repurchases for 2024 expected between $160 million–$180 million.
Statutory margin for GLIC expected to remain in the $500 million–$1 billion range.
Latest events from Genworth Financial
- Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025 - Board recommends approval of all key proposals, including director elections and compensation.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025